Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
THERAVANCE BIOPHARMA INC
Ticker: TBPH
CUSIP: G8807B106
Class: Common Stock
DAFNA Capital Management LLC's Holding History (CIK: 0001389933)
Note: Option positions (PUT/CALL) are excluded.
Q2 2021
Shares
732,345
Value ($000)
$10,634
Avg Close
$18.78
Range
$14.46 - $22.74
Q1 2021
Shares
41,165
Value ($000)
$840
Avg Close
$19.01
Range
$16.46 - $21.21
Period
Shares
Value ($000)
Average Close
Price Range
Q2 2021
732,345
$10,634
$18.78
$14.46 - $22.74
Q1 2021
41,165
$840
$19.01
$16.46 - $21.21